Press release
Hydroxychloroquine Market Evaluation Targets Advancement Anticipated until 2030
Get all Report Details@ https://www.factmr.com/report/4769/hydroxychloroquine-market
In 2020, from January to April, India has exported hydroxychloroquine API (active pharmaceutical ingredient) worth US$ 1.2 Bn. Attributed to above-mentioned facts global hydroxychloroquine market is estimated to experience a year on year growth of over 100% by the end of 2020.
Key Takeaways of Hydroxychloroquine Market Study
Due to skyrocketing demand for hydroxychloroquine, the global hydroxychloroquine market is expected to create a value opportunity of around US$ 2.3 Bn by the end of 2020.
The coronavirus pandemic has spiked the prices of API (active pharmaceutical ingredients) which is set to increase the market value by 2X through 2020.
Based on drug type, anti-rheumatic drug has dominated the consumption of hydroxychloroquine in 2018 and is poised to account for nearly half of the market share by 2030.
Due to the high prevalence of rheumatoid arthritis and systemic lupus erythematosus, United Stated is projected to remain a highly lucrative region during the forecast period.
In terms of production, currently, India accounted for nearly half of the global production in 2019.
“Increasing prevalence of rheumatoid arthritis and systemic lupus erythematosus across the globe is poised to amplify the hydroxychloroquine market growth during the forecast period. The COVID-19 crisis will give an uptick to sales”, says the Fact.MR analyst.
To remain ‘ahead’ of your competitors, request for a sample @ https://www.factmr.com/connectus/sample?flag=S&rep_id=4769
Capacity Expansions to Meet the Skyrocketing Demand for Hydroxychloroquine
The players of hydroxychloroquine include Abcam plc, Advanz Pharma, Amneal Pharmaceuticals Inc, Bayer AG, Dr Reddy's Lab, Ipca Laboratories Ltd.
, Laurus Labs and Mylan. In order to meet the increasing demand of hydroxychloroquine tablets, market goliaths have increased their production capabilities. Companies like Amneal Pharmaceuticals Inc, Bayer AG, Dr Reddy's Lab, Ipca Laboratories Ltd, Zydus Cadila and Mylan have expanded their production capacities to meet the increasing the demand of hydroxychloroquine.
Market titans have also decided to ramp up their production capacities further if demand increases in the upcoming months.
To get exclusive insights on the keyword market, request for methodology here@ https://www.factmr.com/connectus/sample?flag=RM&rep_id=4769
More Valuable Insights on Hydroxychloroquine Market:
Fact.MR, in its new offering, presents an unbiased analysis of the global hydroxychloroquine market, presenting historical demand data (2015-2019) and forecast statistics for the period of 2020-2030.
For comprehensive insights on keyword adoption, ask an analyst here@ https://www.factmr.com/connectus/sample?flag=AE&rep_id=4769
The study divulges essential insights on the Hydroxychloroquine market on the basis of drug type (anti-malarial drug, anti-rheumatic drug, lupus suppressant drug, anti COVID 19 drug and others) across six major regions.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A, franklin. arnold
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hydroxychloroquine Market Evaluation Targets Advancement Anticipated until 2030 here
News-ID: 2240869 • Views: …
More Releases from Fact.MR
Insights into the Medical Gloves Market to Exceed US$ 27 Billion by 2034
The global medical gloves market (医療用手袋市場) is projected to reach a valuation of over US$ 27,141.5 million by 2034, growing from an estimated worth of US$ 11,299 million in 2024, with a forecasted compound annual growth rate (CAGR) of 9.2% until 2034.
The increasing emphasis on hygiene and infection control, particularly in healthcare environments, is driving demand for medical gloves. This demand is further fueled by stringent regulations governing healthcare standards.…
Aerial Inspection Services Market is accelerate at a CAGR of 17.5% to top US$ 9. …
The global Aerial Inspection Services is expected to reach a value of US$ 1.9 billion and is projected to grow at a compound annual growth rate (CAGR) of 17.5% over the next decade, reaching US$ 9.5 billion by 2033.Drone inspection services dominate this market, accounting for approximately 90.0% of the total aerial inspection services sector. Moreover, this segment represents a significant portion, around 25.0%, of the broader drone services market,…
Bioink Market Expected to Reach US$ 1.03 Billion by 2034 with 18.8% CAGR
In 2024, the global bioink market (バイオインク市場) is estimated at US$ 185.6 million. Forecasts project a remarkable Compound Annual Growth Rate (CAGR) of 18.8%, catapulting the demand for bioinks to reach a substantial market value of US$ 1.03 billion by 2034.
Recent years have witnessed a consistent rise in the necessity for organ replacements and tissue regeneration. Innovations in these fields are anticipated to facilitate the transformation of damaged tissues into…
Bonded Magnet Market is forecast to reach a valuation of US$ 10.9 Billion by 203 …
The Bonded Magnet Market is currently valued at around US$ 5.1 billion, and it is expected to experience substantial growth in the coming years. Projections suggest that the market will reach a valuation of US$ 10.9 billion by 2032, growing at an impressive compound annual growth rate (CAGR) of 7.8% from 2022 to 2032.
Bonded magnets play a significant role in the global magnet market, accounting for approximately 14% of its…
More Releases for Hydroxychloroquine
Global Hydroxychloroquine Sulphate Market Size 2028 Trend & Forecast Report
An exceptional companion Hydroxychloroquine Sulphate Market report takes into consideration diverse segments of the market analysis that today's business ask for. The report provides estimations of CAGR values, market drivers and market restraints about the Veterinary Diagnostics industry which are helpful for the businesses in deciding upon numerous strategies. The base year for calculation in the report is taken as 2022 whereas the historic year is 2019 which will tell…
Increasing Burden of Malaria Providing Traction to Hydroxychloroquine Consumptio …
In the wake of the worsening coronavirus pandemic, hydroxychloroquine has been touted as a key drug in the treatment and eradication of COVID-19. As a result, the demand for hydroxychloroquine has skyrocketed in the past few weeks. The United States alone has generated significant demand for 20 million hydroxychloroquine pills, amounting to 4 tons. Moreover, the global demand for hydroxychloroquine is anticipated to surge amid the rapidly increasing COVID-19 infections.…
Hydroxychloroquine Sulphate Market 2021 | Detailed Report
ReportsnReports publishes the report titled Hydroxychloroquine Sulphate that presents a 360-degree overview of the market under one roof. The report is developed with the meticulous efforts of an enthusiastic and experienced team of experts, analyts, and researchers that makes the report a valuable asset for stakeholders to make robust decisions. This report also provides an in-depth overview of product type, specification, technology, and production analysis considering vital factors like cost,…
Global Hydroxychloroquine Market Is Growing Rapidly as Sanofi and Teva Pharmaceu …
Hydroxychloroquine (Plaquenil and Hydrochloroquin) are commonly used in the treatment of osteoarthritis. Hydroxychloroquine and Hydroxyquinone (Dilantin) are considered "anti-inflammatory" medicines. They inhibit the action of prostaglandins and leukotrienes on the skin, joints, and tendons. It can reduce swelling and pain associated with arthritis. Hydroxychloroquine is in a category of drugs known as "dilators" which were first introduced to control and prevent arthritis from occurring. Hydroxychloroquine (Plaquenil), commonly referred to as…
Hydroxychloroquine Sulfate Market Predicted to Accelerate the Growth by 2030
Hydroxychloroquine Sulfate: The Rescuer in COVID-19 Crisis
Hydroxychloroquine (HCQ), is a drug used to forestall and treat jungle fever in zones where intestinal sickness stays touchy to chloroquine. Other utilizations incorporate treatment of rheumatoid joint pain, lupus, and porphyria cutanea tarda. Furthermore, hydroxychloroquine sulfate is the highly touted drug that’s taken for center stage due to its potential to treat patients with COVID-19. As result of this demand for hydroxychloroquine sulfate…
Hydroxychloroquine Market Worth Observing Growth: Theravance Biopharma, Pfizer, …
The latest 98+ page survey report on Global Hydroxychloroquine Market is released by HTF MI covering various players of the industry selected from global geographies like North America, Europe, Asia-Pacific etc. A perfect mix of quantitative & qualitative Market information highlighting developments, industry challenges that competitors are facing along with gaps and opportunity available and would trend in Hydroxychloroquine market. The study bridges the historical data from 2014 to 2019…
